ScreenerHero
CORCencora, Inc.
NYSE · US · Healthcare · Medical Distribution · cencora.com
271.28USD-0.20%Mkt Cap: 52.78B $P/E: 20.79

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter…

Industry Peers

Medical Distribution
Screen all
vs Medical Distribution
P/E
Avg
P/B
Pricier
Div Yield
Avg
1M Perf
Lower
MCK
McKesson Corporation
$87.21BUSDP/E 19.4
-126.7% 1M
CAH
Cardinal Health, Inc.
$52.17BUSDP/E 34.1
+1180.0% 1M
HSIC
Henry Schein, Inc.
$8.96BUSDP/E 23.8
+742.9% 1M
GALE
Galenica AG
$4.79BUSDP/E 23.0
+162.8% 1M
AMP
Amplifon S.p.A.
$2.88BUSDP/E 32.2
-361.4% 1M
ASKER
Asker Healthcare Group AB (publ)
$2.56BUSDP/E 44.9
-1530.5% 1M
SELEC
Selçuk Ecza Deposu Ticaret ve Sanayi A.S.
$2.74BUSDP/E 99.1
+8504.0% 1M
UPR
Uniphar plc
$1.28BUSDP/E 22.7
+22.1% 1M
ARJO-B
Arjo AB (publ)
$633.08MUSDP/E 18.8
-463.1% 1M
M12
M1 Kliniken AG
$373.93MUSDP/E 15.4
-378.1% 1M
ILM1
Medios AG
$343.22MUSDP/E 22.1
-802.4% 1M
BLC
Bastide Le Confort Médical SA
$185.90MUSDP/E 18.6
-1153.1% 1M
MLFMV
Farminveste, S.G.P.S., S.A.
$114.13MUSD
+5294.1% 1M
NAVA
Navamedic ASA
$36.99MUSD
-958.9% 1M
ALEMG
Laboratoires Euromedis Société anonyme
$16.61MUSDP/E 14.1
+918.4% 1M
RMAH
Farmaceutica REMEDIA S.A.
$16.17MUSDP/E 9.9
-1261.1% 1M
Indicators:|

Key Statistics

Company
Market Cap52.78B $
Enterprise Value65.99B $
Revenue (TTM)328.68B $
Gross Profit11.48B $
Net Income (TTM)1.55B $
Revenue/Share1693.17 USD
Last Price271.28 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees47.0K
CountryUS
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)20.79
P/E (Forward)13.74
PEG0.58
EV/EBITDA12.45
EV/Revenue0.20
P/S0.16
P/B15.57
EPS (TTM)13.05
EPS (Forward)19.79
52W Range
244.8220% of range377.54
52W High377.54 USD
52W Low244.82 USD
Profitability
Gross Margin3.57%
Oper. Margin1.72%
EBITDA Margin1.61%
Profit Margin0.48%
ROE103.06%
ROA2.03%
Growth
Revenue Growth3.80%
Earnings Growth128.30%
Cash Flow & Leverage
Operating CF3.88B $
CapEx (TTM)667.98M $
FCF Margin-0.10%
FCF Yield-0.60%
Net Debt12.92B $
Net Debt/EBITDA2.44
Balance Sheet
Debt/Equity5.08
Current Ratio0.95
Quick Ratio0.48
Book Value/Sh17.46 USD
Cash/Share11.19 USD
Dividends
Fwd Div Rate2.400 USD
Trail. Div Rate2.300 USD
Div. Yield0.88%
5Y Avg Yield1.01%
Payout Ratio17.62%
Ex-Div DateMay 15, 2026
Pay DateJun 1, 2026
Splits
Last Split2:1
Split DateJun 16, 2009
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)350.58 USD
Upside (mean)+29.2%
Target Range280.00 USD – 412.00 USD
$280.00+29.2% to mean$412.00
# Analysts12
Ownership
Shares Out.194.56M
Float184.01M
Insiders4.23%
Institutions98.76%
Short Interest
Short Ratio2.4d
Short % Float3.22%
Short % Out.2.84%
Shares Short5.53M
Short (prev mo.)5.19M
Technical
SMA 50285.78 (-5.1%)
SMA 200324.84 (-16.5%)
Beta0.59
S&P 52W Chg24.49%
Avg Vol (30d)1.46M
Avg Vol (10d)1.42M
Technical Indicators
RSI (14)43.0
MACD-1.2043
MACD Signal-2.2370
MACD Hist.+1.0327
BB Upper285.88 USD
BB Middle273.74 USD
BB Lower261.60 USD
BB Width8.87%
ATR (14)6.878 USD
Vol Ratio (20d)1.60x